Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
1,717,524
-
Share change
-
+6,401
-
Total reported value
-
$202,824,933
-
Price per share
-
$118.10
-
Number of holders
-
78
-
Value change
-
+$755,816
-
Number of buys
-
2
-
Number of sells
-
1
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q4 2013
As of 31 Dec 2013,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,717,524 shares.
The largest 10 holders included
MORGAN STANLEY, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, ARS Wealth Advisors, LLC, BROWN ADVISORY INC, CLS Investments, LLC, ROYAL BANK OF CANADA, Raymond James Financial Services Advisors, Inc., SPC Financial, Inc., and BANK OF MONTREAL /CAN/.
This page lists
78
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.